NCT00395291 Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients Status COMPLETED Phase NA
NCT00394914 Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) Status COMPLETED Phase PHASE2
NCT00394784 Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates Status WITHDRAWN Phase N/A
NCT00393445 Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans Status COMPLETED Phase PHASE1
NCT00392574 Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea Status COMPLETED Phase PHASE3
NCT00392171 The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) Status COMPLETED Phase PHASE2
NCT00390260 Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00389987 Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) Status COMPLETED Phase PHASE3
NCT00387140 A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain (MK-2295-005) Status COMPLETED Phase PHASE2
NCT00387036 Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036) Status TERMINATED Phase PHASE2
NCT00384605 An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED) Status TERMINATED Phase PHASE3
NCT00384293 Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED) Status TERMINATED Phase PHASE3
NCT00381017 Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) Status WITHDRAWN Phase PHASE3
NCT00380367 Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) Status COMPLETED Phase PHASE3
NCT00379964 A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) Status COMPLETED Phase PHASE3